Total Organic Carbon (VCSN and VWP) and HPLC Analysis for Cleaning Validation in a Pharmaceutical Pilot Plant

7. References

1. 1.↵
   European Commission. Working Party on Control of Medicines and Inspections. Annex 15 to the EU Guide to Good Manufacturing Practice. Qualification and Validation. European Commission: Brussels, 2001. http://ec.europa.eu/enterprise/pharmaceuticals/eudralex/vol-4/pdfs-en/v4an15.pdf. Accessed December 5, 2007.
2. 2.↵
   Office of Regulatory Affairs, FDA. Guide to Inspections Validation of Cleaning Processes. www.fda.gov/ora/inspect_ref/igs/valid.html. Accessed December 5, 2005.
3. 3.↵
   1. Salazar R.

   Validación Industrial. In Su Aplicación a la Industria Farmacéutica y Afines, 1st ed., Romagraf: Barcelona, Spain, 1999; p 386– 414.
4. 4.↵
   Center for Drug Evaluation and Research, FDA. Can Total Organic Carbon (TOC) be an acceptable method for detecting residues of contaminants in evaluating cleaning effectiveness? Questions and Answers on Current Good Manufacturing Practices, Good Guidance Practices, Level 2 Guidance; Equipment. http://www.fda.gov/cder/guidance/cGMPs/equipment.htm#TOC. Accessed 11/06/05.
5. 5.↵
   1. LeBlanc D. A.

   Equipment Cleaning. Encyclopaedia of Pharmaceutical Technology; 3rd ed.; Informa Healthcare USA, Inc.: New York, 2006; pp 1580– 1592.
6. 6.↵
   1. Forsyth R. J.,
   2. Leblanc A.,
   3. Voaden M.

   A single adulteration limit for cleaning validation in a pharmaceutical pilot plant environment. Pharm. Technol. 2007, 1 2, http://www.pharmtech.com/pharmtech/Validation+and+compliance/A-Single-Adulteration-Limit-for-Cleaning-Validatio/ArticleStandard/Article/detail/397397. Accessed 12/02/2007.
7. 7.↵
   1. Forsyth R.,
   2. Van Nostrand V.

   Using visible residue limits for introducing new compounds into a pharmaceutical research facility. Pharm. Technol. 2005, 29 ( 4), 134– 140.

   OpenUrl
8. 8.↵
   1. Martínez J. E.

   Cleaning validation for developmental, stability and clinical lots. Pharm. Technol. 2002, 26 ( 11), 62– 74.

   OpenUrl
9. 9.↵
   Asociación Española de Farmacéuticos de la Industria (AEFI). Validación de Métodos Analíticos, 1st ed.; AEFI: Madrid, 2001; p 121.
10. 10.↵
    1. Jenkins K. M.,
    2. Vanderwielen A. J.,
    3. Armstrong J. A.,
    4. Leonard L. M.,
    5. Murphy G. P.,
    6. Piros N. A.

    Application of total organic carbon analysis to cleaning validation. PDA J. Pharm. Sci. Technol. 1996, 50 ( 1), 6– 15.

    OpenUrlAbstract/FREE Full Text
11. 11.↵
    1. Biwald C. E.,
    2. Gavlick W. K.

    Use of total organic carbon analysis and Fourier-transform infrared spectroscopy to determine residues of cleaning agents on surfaces. J. AOAC Int. 1997, 80 ( 5), 1078– 1083.

    OpenUrl
12. 12.↵
    1. Gavlick W.,
    2. Ohlemeier L. A.,
    3. Kaiser H. J.

    Analytical strategies for cleaning agent residue determination. Pharm. Technol. 1995, 19 ( 3), 136– 144.

    OpenUrl
13. 13.↵
    Anatel Corporation. The Determination of CIP-100 Residues on Stainless Steel Surfaces by Total Organic Carbon Analysis. Application Note 12.99.3, 1999.
14. 14.↵
    1. Baffi R. A.,
    2. Dolch G.,
    3. Garnick R.,
    4. Huang Y. F.,
    5. Mar B.,
    6. Matsuhiro D.,
    7. Niepelt B.,
    8. Parra C.,
    9. Stephan M.

    Total organic carbon analysis method for validating cleaning between products in biopharmaceutical manufacturing. J. Parent. Sci. Technol. 1991, 45 ( 1), 13– 19.

    OpenUrl
15. 15.↵
    1. Smith J.

    Selecting analytical methods from cleaning compounds in validated process systems. Pharm. Technol. 1993, 17, 88– 98.

    OpenUrl
16. 16.↵
    1. LeBlanc D.

    Cleaning technology for pharmaceutical manufacturing. Pharm. Technol. 1993, 17, 84– 92.

    OpenUrl
17. 17.↵
    1. Holmes A. J.,
    2. Vanderwielen A. J.

    Total organic carbon method for aspirin cleaning validation. PDA J. Pharm. Sci. Technol. 1997, 51 ( 4), 149– 152.

    OpenUrlAbstract/FREE Full Text
18. 18.↵
    1. Westman L.,
    2. Karlsson G.

    Methods for detecting residues of cleaning agents during cleaning validation. PDA J. Pharm. Sci. Technol. 2000, 54 ( 5), 365– 372.

    OpenUrlAbstract/FREE Full Text
19. 19.↵
    1. Glover C.

    Validation of the total organic carbon (TOC) swab sampling and test method. PDA J. Pharm. Sci. Technol. 2006, 60 ( 5), 284– 290.

    OpenUrlAbstract/FREE Full Text
20. 20.↵
    Shimadzu. TOC-V_CSN User's Manual. Shimadzu Corporation: Kyoto, 2001.
21. 21.↵
    Shimadzu. TOC-V_WP User's Manual. Shimadzu Corporation: Kyoto, 2001.
22. 22.↵
    Cleaning Validation Swabs. www.texwipe.com. Accessed January 17, 2006.
23. 23.↵
    Real Farmacopea Española (RFE), 3rd ed.; Madrid, Spain, 2005; p 71.
24. 24.↵
    United States Pharmacopoeia USP30 NF25, 〈 641〉, 2007.
25. 25.↵
    Anatel Corporation. Total Organic Carbon Analysis for Cleaning Validation in Pharmaceutical Manufacturing. Application Note 12.99.2, 1999.
26. 26.↵
    American Association of Official Analytical Chemists (AOAC) Requirements for Single Laboratory Validation of Chemical Methods. http://www.aoac.org/Ag_Materials/additives/aoac_slv.pdf. Accessed May 29, 2007.
27. 27.↵
    International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). Validation of analytical procedures: text and methodology Q2 (R1). http://www.ich.org/LOB/media/MEDIA417.pdf. Accessed May 29, 2007.
28. 28.↵
    1. Fontané i Miret M.

    Validación de Procesos de Limpieza en la Industria Farmacéutica. Thesis, Universidad de Barcelona, 2000.
29. 29.↵
    1. LeBlanc A.

    Establishing scientifically justified acceptance criteria for cleaning validation of finished drug products. Pharm. Technol. 1998, 22 ( 10), 136– 148.

    OpenUrl
30. 30.↵
    1. LeBlanc A.

    Establishing scientifically justified acceptance criteria for the cleaning validation of APIs. Pharm. Technol. 2000, 24 ( 10), 160– 168.

    OpenUrl
31. 31.↵
    1. Forsyth R.,
    2. Van Nostrand V.

    Application of visible-residue limit for cleaning validation in a pharmaceutical manufacturing facility. Pharm Technol. 2005, 29 ( 10), 152– 161.

    OpenUrl
32. 32.↵
    1. Forsyth R.,
    2. Hartman J.,
    3. Van Nostrand V.

    Risk-management assessment of visible-residue Limits in Cleaning Validation. Pharm. Technol. 2006, 30 ( 9), 104– 114.

    OpenUrl
33. 33.↵
    1. Nash R. A.,
    2. Wachter A. H.

    1. Hall W. E.

    Validation and Verification of Cleaning Processes. In Pharmaceutical Process Validation, 3rd ed.; Nash R. A., Wachter A. H. Eds.; Marcel Dekker, Inc.: New York, 2003; Vol. 129, p 493.

    OpenUrl
34. 34.↵
    1. Fourman G. L.,
    2. Mullen M. V.

    Determining cleaning validation acceptance limits for pharmaceutical manufacturing operations. Pharm. Technol. 1993, 17 ( 4), 54– 60.

    OpenUrl
35. 35.↵
    1. Wallace B.,
    2. Stevens R.,
    3. Purcell M.

    Implementing total organic carbon analysis for cleaning validation. Pharm. Technol. Aseptic Processing 2004, Supplement, 40– 43.
36. 36.↵
    1. Le Blanc D.

    Rinse sampling for cleaning validation studies. Pharm. Technol. 1998, 22 ( 5), 66– 74.

    OpenUrl
37. 37.↵
    1. Nash R. A.,
    2. Wachter A. H.

    1. Hall W. E.

    Validation and Verification of Cleaning Processes. In Pharmaceutical Process Validation, 3rd ed.; Nash R. A., Wachter A. H. Eds.; Marcel Dekker, Inc.: New York, 2003; Vol. 129, p 484.

    OpenUrl
38. 38.↵
    1. Yang P.,
    2. Burson K.,
    3. Feder D.,
    4. Macdonald F.

    Method development of swab sampling for cleaning validation of a residue active pharmaceutical ingredient. Pharm. Technol. 2005, 29, 84– 94.

    OpenUrl
39. 39.↵
    1. Juarbe N.,
    2. Strege M.

    Validation of a method for the determination of polysorbate 20 residue for the support of the cleaning of pharmaceutical vial closures. J. Validation Technol. 2007, 13 ( 2), 114– 123.

    OpenUrl